FdaApplication
ANDA 215635
Identifiers
- fda_app_no: ANDA215635
Properties
| Property | Value |
|---|---|
| applicant_name | NIVAGEN PHARMACEUTICALS LLC |
| application_type | ANDA |
| approval_date | 2024-06-28 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| REMIFENTANIL HYDROCHLORIDE | REMIFENTANIL HYDROCHLORIDE | EQ 5MG BASE/VIAL | INJECTABLE;INJECTION |
| REMIFENTANIL HYDROCHLORIDE | REMIFENTANIL HYDROCHLORIDE | EQ 2MG BASE/VIAL | INJECTABLE;INJECTION |
| REMIFENTANIL HYDROCHLORIDE | REMIFENTANIL HYDROCHLORIDE | EQ 1MG BASE/VIAL | INJECTABLE;INJECTION |
3 products